LOMEFLOXACIN-INDUCED MODIFICATION OF THE KINETICS OF GROWTH OF GRAM-NEGATIVE BACTERIA AND SUSCEPTIBILITY TO PHAGOCYTIC KILLING BY HUMAN NEUTROPHILS

被引:29
作者
PRUUL, H [1 ]
MCDONALD, PJ [1 ]
机构
[1] FLINDERS UNIV,SCH MED,CLIN MICROBIOL UNIT,BEDFORD PK,SA 5042,AUSTRALIA
关键词
D O I
10.1093/jac/25.1.91
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The post-antibiotic effect (PAE) of lomefloxacin against Escherichia coli and Pseudomonas aeruginosa was determined and compared with various other antibiotics. All the quinolones tested, and chloramphenicol and gentamicin, possessed PAE activity. At 10 × MIC and 30min exposure, the PAEs against E. coli were 1·6, 1·3, and 1·8 h for lomefloxacin, ciprofloxacin and norfloxacin respectively, and for P. aeruginosa the equivalent PAEs were 1·1, 1 and 0·5 h. The lomefloxacin PAE was dose-dependent and exposure for 5min was sufficient to give optimal PAE at high concentrations of lomefloxacin. Such brief exposure rapidly blocked bacterial nucleic acid biosynthesis. Lomefloxacin pretreated bacteria were more susceptible to killing by PMN than untreated bacteria. Optimum enhancement of phagocytic killing of E. coli occurred when exposure to lomefloxacin was associated with an 80% decrease in cfu during pretreatment. Maximum PMN activity against P. aeruginosa occurred when bacteria were exposed to lomefloxacin producing change in cfu of + 0·2 log10 to -0·7 log10. These results indicate that phenotypic changes of P. aeruginosa and E. coli exposed to lomefloxacin render the bacteria more susceptible to phagocytic killing. © 1990 The British Society for Antimicrobial Chemotherapy.
引用
收藏
页码:91 / 101
页数:11
相关论文
共 19 条
[1]  
ALEXANDER JW, 1968, J LAB CLIN MED, V71, P971
[2]  
BENBROOK DM, 1986, ANTIMICROB AGENTS CH, V29, P1, DOI 10.1128/AAC.29.1.1
[3]   INVITRO ACTIVITY OF LOMEFLOXACIN (SC-47111-NY-198), A DIFLUOROQUINOLONE 3-CARBOXYLIC ACID, COMPARED WITH THOSE OF OTHER QUINOLONES [J].
CHIN, NX ;
NOVELLI, A ;
NEU, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (05) :656-662
[4]   CONTINUOUS VS DISCONTINUOUS THERAPY WITH PENICILLIN - THE EFFECT OF THE INTERVAL BETWEEN INJECTIONS ON THERAPEUTIC EFFICACY [J].
EAGLE, H ;
FLEISCHMAN, R ;
LEVY, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1953, 248 (12) :481-488
[5]   INVITRO ASSESSMENT OF LOMEFLOXACIN (SC-47111) - A NEW QUINOLONE DERIVATIVE [J].
FINCH, R ;
MARTIN, J ;
PILKINGTON, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :881-884
[6]   DNA TOPOISOMERASES [J].
GELLERT, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1981, 50 :879-910
[7]   REGULATION OF PROTEIN-A BIOSYNTHESIS IN STAPHYLOCOCCUS-AUREUS BY CERTAIN ANTIBIOTICS - ITS EFFECT ON PHAGOCYTOSIS BY LEUKOCYTES [J].
GEMMELL, CG ;
ODOWD, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1983, 12 (06) :587-597
[8]   HYPERSUSCEPTIBILITY OF PENICILLIN-TREATED GROUP-B STREPTOCOCCI TO BACTERICIDAL ACTIVITY OF HUMAN POLYMORPHONUCLEAR LEUKOCYTES [J].
HORNE, D ;
TOMASZ, A .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1981, 19 (05) :745-753
[9]   BACTERICIDAL ACTIVITY OF CIPROFLOXACIN IN SERUM AND URINE AGAINST ESCHERICHIA-COLI, PSEUDOMONAS-AERUGINOSA, KLEBSIELLA-PNEUMONIAE, STAPHYLOCOCCUS-AUREUS AND STREPTOCOCCUS-FAECALIS [J].
LAGAST, H ;
HUSSON, M ;
KLASTERSKY, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1985, 16 (03) :341-347
[10]  
LAM C, 1982, INFLUENCE ANTIBIOTIC, P242